Thor Medical ASA (OSL:TRMED)

Norway flag Norway · Delayed Price · Currency is NOK
4.170
+0.135 (3.35%)
Mar 3, 2026, 4:25 PM CET
78.59%
Market Cap 1.45B
Revenue (ttm) 100.00K
Net Income (ttm) -58.91M
Shares Out 359.78M
EPS (ttm) -0.22
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,688,529
Average Volume 2,652,920
Open 4.020
Previous Close 4.035
Day's Range 3.935 - 4.245
52-Week Range 1.804 - 5.490
Beta -0.04
RSI 41.15
Earnings Date Feb 26, 2026

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 13
Stock Exchange Oslo Børs
Ticker Symbol TRMED
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.